CompanyJBIONasdaqWaltham, MA

Jade Biosciences, Inc.

Jade Biosciences is a clinical-stage biotechnology company developing monoclonal antibodies for autoimmune diseases.

SEC EDGAR ClinicalTrials.gov jadebiosciences.com

8-KSep 30Latest SEC filing

Aug 10Latest story

August 2026

Jade Biosciences reports positive Phase 1 data for JADE101, advances pipeline

Aug 10Quarterly updateJade Biosciences, Inc.JADE101

July 2026

Jade Biosciences licenses undisclosed target antibody program from Paragon

Jul 1PartnershipJade Biosciences, Inc.